{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "regularMarketChangePercent": 0.0, "regularMarketPrice": 0.0147, "marketState": "PRE", "currency": "USD", "exchange": "PNK", "shortName": "VAXIL BIO LTD (CA)", "longName": "Vaxil Bio Ltd.", "messageBoardId": "finmb_108333814", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "fiftyDayAverageChangePercent": 0.06924642, "twoHundredDayAverage": 0.0166911, "twoHundredDayAverageChange": -0.0019910997, "twoHundredDayAverageChangePercent": -0.119291104, "marketCap": 2020823, "priceToBook": 1.8375, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1459344600000, "priceHint": 4, "regularMarketChange": 0.0, "regularMarketTime": 1683906136, "regularMarketDayHigh": 0.0147, "regularMarketDayRange": "0.0147 - 0.0147", "regularMarketDayLow": 0.0147, "regularMarketVolume": 10000, "regularMarketPreviousClose": 0.0147, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "fullExchangeName": "Other OTC", "financialCurrency": "CAD", "regularMarketOpen": 0.0147, "averageDailyVolume3Month": 31699, "averageDailyVolume10Day": 27465, "fiftyTwoWeekLowChange": 0.010500001, "fiftyTwoWeekLowChangePercent": 2.5000002, "fiftyTwoWeekRange": "0.0042 - 0.034", "fiftyTwoWeekHighChange": -0.019300003, "fiftyTwoWeekHighChangePercent": -0.5676471, "fiftyTwoWeekLow": 0.0042, "fiftyTwoWeekHigh": 0.034, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.01, "sharesOutstanding": 136979008, "bookValue": 0.008, "fiftyDayAverage": 0.013748, "fiftyDayAverageChange": 0.0009519998, "displayName": "Vaxil Bio", "symbol": "VXLLF"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "3400 One First Canadian Place", "city": "Toronto", "state": "ON", "zip": "M5X 1A4", "country": "Canada", "website": "https://www.vaxil-bio.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Vaxil Bio Ltd., a biotechnology company, focuses on a novel drug discovery and development platform based on signal peptides for infectious diseases and cancer. The company's lead product is ImMucin that has completed a Phase I/II clinical trial for the treatment of multiple myeloma. It is also developing a tuberculosis vaccine/treatment and a coronavirus (COVID-19) vaccine. The company has a collaboration agreement with The Tel Aviv Sourasky Medical Center for the company's research program to develop a potential peptide vaccine against COVID-19; and cooperative research and development agreement with U.S. Army Medical Research Institute of Infectious Diseases for testing CorVax for its ability to prevent COVID-19 in mice. The company was founded in 2006 and is headquartered in Toronto, Canada.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Gadi  Levin B.Com., C.A., CPA, M.B.A., MBA", "age": 49, "title": "Chairman & CFO", "yearBorn": 1973, "fiscalYear": 2021, "totalPay": {"raw": 72289, "fmt": "72.29k", "longFmt": "72,289"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Yuval  Avnir Ph.D.", "title": "Head of R&D & CEO", "fiscalYear": 2021, "totalPay": {"raw": 39095, "fmt": "39.09k", "longFmt": "39,095"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Riva  Kovjazin M.D.", "title": "Sr. Scientist & Member of Scientific Advisory Board", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1640908800, "maxAge": 86400}}], "error": null}}